Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke–Korsakoff Syndrome: A Nationwide Register Study in Finland
Journal of Clinical Medicine · 25.06.2023 · 12 (13) · 4263
DOI: 10.3390/jcm12134263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.06.2023. Verfasst von Anniina Palm und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Helsinki University Hospital, 00029 Helsinki, Finland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsinki University Hospital.
Themen: Demenz
Abstract (Originalsprache)
Background
Research on the use of psychotropic drugs in people with alcohol-related neurocognitive disorders is virtually nonexistent. We examined the prevalence of antipsychotic drug use and its effect on mortality among patients with Wernicke–Korsakoff syndrome (WKS) or alcohol-related dementia (ARD).
Methods
In this nationwide register study, we collected data on the medication use and mortality of all persons aged ≥40 diagnosed with WKS (n = 1149) or ARD (n = 2432) between 1998 and 2015 in Finland. We calculated the prevalence of antipsychotic use within one year of diagnosis and the adjusted cumulative mortality of antipsychotic users versus non-users in relation to the age-, sex-, and calendar year-matched general population.
Results
Of the WKS and ARD patients, 35.9% and 38.5%, respectively, purchased one or more antipsychotic drugs in the year following diagnosis. The adjusted cumulative mortality of the antipsychotic users was significantly lower than that of non-users in both the WKS and ARD groups, where the adjusted hazard ratios (95% CI) were 0.85 (0.72–0.99) and 0.73 (0.65–0.81), respectively. WKS and ARD patients using antipsychotics were less likely to die of alcohol-related causes than antipsychotic non-users, but the difference was significant only in the ARD group.
Conclusions
This population-based study shows that antipsychotic use is common in patients with WKS or ARD. In contrast to other dementia studies, our results indicate that the mortality of antipsychotic users is significantly lower than that of non-users. The lower mortality could be explained by decreased alcohol use and better healthcare coverage in antipsychotic users.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Helsinki University Hospital, 00029 Helsinki, Finland.
- University of Helsinki, 00014 Helsinki, Finland.
- Primary Health Care Unit, Kuopio University Hospital, 70210 Kuopio, Finland.
- Folkhälsan Research Center, 00250 Helsinki, Finland.
- Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.
ORCID-Profile: Anniina Palm, Jaana Suvisaari
Förderung
- Helsinki University Hospital
Zitieren
APA
Palm, A., Talaslahti, T., Vataja, R., Ginters, M., Kautiainen, H., Elonheimo, H., Suvisaari, J., Lindberg, N., & Koponen, H. (2023). Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke–Korsakoff Syndrome: A Nationwide Register Study in Finland. Journal of Clinical Medicine, 12(13), 4263. https://doi.org/10.3390/jcm12134263
Vancouver
Palm A, Talaslahti T, Vataja R, Ginters M, Kautiainen H, Elonheimo H, et al. Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke–Korsakoff Syndrome: A Nationwide Register Study in Finland. Journal of Clinical Medicine. 2023;12(13):4263. doi:10.3390/jcm12134263
BibTeX
@article{Palm2023,
author = {Palm, Anniina and Talaslahti, Tiina and Vataja, Risto and Ginters, Milena and Kautiainen, Hannu and Elonheimo, Henrik and Suvisaari, Jaana and Lindberg, Nina and Koponen, Hannu},
title = {Antipsychotic Use and Mortality in Persons with Alcohol-Related Dementia or Wernicke–Korsakoff Syndrome: A Nationwide Register Study in Finland},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {13},
pages = {4263},
doi = {10.3390/jcm12134263}
}
EUVIMED